Predicate |
Object |
contentType |
Journal Article |
endingPage |
23 |
issn |
2090-0252 |
pageRange |
505607-23 |
publicationName |
International Journal of Alzheimer's Disease |
startingPage |
505607 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9004bbe27f4177679e6b335116c79718 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aec4825d20e6536fa94395fa864468ce |
isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_292a8f5c09355d29717fde037b121bd6 |
bibliographicCitation |
Sutherland C. What Are thebona fideGSK3 Substrates? International Journal of Alzheimer's Disease. 2011;2011():1–23. doi: 10.4061/2011/505607. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4398-7434 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c3f7d8fe7ff0487b38a83ccf7371cf3 |
date |
2011 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3100594 https://pubmed.ncbi.nlm.nih.gov/21629754 https://doi.org/10.4061/2011/505607 |
isPartOf |
https://portal.issn.org/resource/ISSN/2090-0252 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37498 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
What Are thebona fideGSK3 Substrates? |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8369f7c690795caa54317214d5efb891 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4c4bdf82d37a2ce63b2f824bcede49bf |